Trial Profile
Effect of a 15-day Memantine Treatment on Biomarkers of AD in Healthy Volunteers
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 03 Jun 2021
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Alzheimer's disease
- Focus Biomarker; Pharmacodynamics
- 25 Jun 2019 Planned End Date changed from 1 Feb 2019 to 1 Sep 2020.
- 25 Jun 2019 Planned primary completion date changed from 1 Jan 2019 to 1 Sep 2020.
- 08 Nov 2017 Planned End Date changed from 1 Feb 2018 to 1 Feb 2019.